£17.9m for Advanced Therapy Treatment Centre network to bolster clinical trial infrastructure in the UK: NIHR, Innovate UK and CGT Catapult align strategically to further improve patient access and the UK’s leadership
The National Institute for Health and Care Research (NIHR), Innovate UK, the Advanced Therapy Treatment Centre Network and the Cell and Gene Therapy Catapult (CGT Catapult) today announce a £17.9 million strategic initiative to enhance the UK environment for advanced therapy medicinal product (ATMP) clinical trials and to keep the UK as a location of choice for advanced therapy research.
Published on the 21st of March 2024. Read the news story here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (5 novembre 2024). £17.9m for Advanced Therapy Treatment Centre network to bolster clinical trial infrastructure in the UK: NIHR, Innovate UK and CGT Catapult align strategically to further improve patient access and the UK’s leadership. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/12mir





